期刊文献+

314例非小细胞肺癌胸内淋巴结转移规律的临床意义 被引量:4

Clinical significance of patterns of intrathoracic lymph node metastasis in non-small cell lung cancer:an analysis of 314 patients
原文传递
导出
摘要 目的 探索NSCLC胸内淋巴结的转移规律,为放疗靶区勾画提供理论依据.方法 回顾分析314例NSCLC术后患者的临床资料,重点探讨胸内淋巴结的分布特点、转移范围,及其与肿瘤大小、病理类型及原发部位的关系.x2检验组间差别.结果 NSCLC术后4、5、7、10、11组淋巴结转移率均>12%,1、2、3、6、8、9组均<12%.原发肿瘤部位与N2组淋巴结转移相近(P=0.102).而原发灶T3、T4期出现N2组淋巴结转移概率较T1、T2期明显增高(17.0%∶11.6%,P=0.002),腺癌较鳞癌N2组更易转移(34.5%∶23.2%,P=0.008).结论 T3、T4期NSCLC及腺癌患者术后放疗靶区勾画时应着重关注第4、5、7、10、11组淋巴结. Objective To investigate the patterns of intrathoracic lymph node metastasis in nonsmall cell lung cancer (NSCLC) and to provide a theoretical basis for the delineation of radiotherapy target volume.Methods A retrospective analysis was performed on the clinical data of 314 NSCLC patients after operation.Our focus was to investigate the distribution characteristics and metastatic extent of intrathoracic lymph nodes and their relationship with tumor size,pathological type,and primary site.Comparisons between groups were made by one-way analysis of variance.Results The frequencies of metastases to lymph nodes at stations 4,5,7,10,and 11 were all above 12%,while those at stations 1,2,3,6,8,and 9 were all below 12%.The lymph node metastasis rate was similar on the primary tumor site (P =0.102).The patients with T3 and T4 NSCLC had a significantly higher frequency of N2 lymph node metastasis than those with T1 and T2 NSCLC (17.0% vs.11.6%,P =0.002) ;the patients with adenocarcinoma had a significantly higher frequency of N2 lymph node metastasis than those with squamous cell carcinoma (34.5 % vs.23.2%,P =0.008).Conclusions For patients with T3 and T4 NSCLC of adenocarcinoma subtype,we should highlight the lymph nodes at stations 4,5,7,10,and 11 when delineating the radiotherapy target volume after operation.
出处 《中华放射肿瘤学杂志》 CSCD 北大核心 2014年第4期294-296,共3页 Chinese Journal of Radiation Oncology
关键词 非小细胞肺癌 肺腺癌 肺鳞癌 淋巴结转移 Non-small cell lung cancer Lung adenocarcinoma Lung squamous carcinoma Lymph node metastasis
  • 相关文献

参考文献11

二级参考文献56

  • 1李玉,王润智.肺癌的淋巴结转移规律与肺癌系统纵隔淋巴结廓清术[J].医师进修杂志(外科版),2004,27(10):6-7. 被引量:11
  • 2周华富,何巍,陈铭伍,覃家锦,廖寿合,冯旭.非小细胞肺癌淋巴结转移规律的临床研究[J].广西医科大学学报,2005,22(5):694-695. 被引量:3
  • 3窦学军,刘树库,陈肖嘉,白连启,许绍发,闫东杰,龚昌帆.外科治疗III_A期N_2非小细胞肺癌的预后分析及临床意义[J].中华胸心血管外科杂志,2006,22(2):105-107. 被引量:18
  • 4Libshitz HI,Mckenna RJ Jr,Mountain CF.Patterns of mediastinal metastasis in bronchogenic carcinoma[J].Chest,1986,90(2):229-232.
  • 5RIQUET M, HIDDEN G, DEBESSE B, et al. Direct lymphatic drainage of lung segment to the mediastinal node. [ J ] . Thorac Cardiocsc Surg, 1989, 97: 623-631.
  • 6孙玉鹗.胸外科手术学[M].北京:人民军医出版社.2004:431.
  • 7罗凌青,张建中,崔海宁,翁杰.155例肺癌患者淋巴结转移的临床研究[J].中国肺癌杂志,2007,10(5):422-424. 被引量:12
  • 8Goya T,Asamura H,Yoshimura H,et al. Prognosis of 6644 resec-ted nonsmall cell lung cancers in Japan: a Japanese lung cancer reg-istry study[ J]. Lung Cancer, 2005,51 (2) : 227 -234.
  • 9Muehling B, Wehrmann C,Oberhuber A,et al. Comparison of clin-ical and surgical-pathological staging in HI A non-small ceil lungcancer patients[ J]. Ann Surg Oncol,2012,19(1) :89 - 93.
  • 10Thomas PA. Stage IE A N2 non-small-cell lung ecancer: currantconotroversles in onmbined-modality therapy [ J ]. Eur J Cardiutho-rae Surg, 2009,36(3) : 431 -432.

共引文献64

同被引文献33

  • 1许川,梅宏,韩连奎,李震宇,刘波,刘迪.早期周围型非小细胞肺癌患者纵隔淋巴结转移的危险因素[J].中国老年学杂志,2014,34(12):3274-3275. 被引量:4
  • 2Groome PA, Bolejack V, Crowley JJ, et al. The IASI C lung cancer staging project:validation of the proposals for revision of the T,Nand M descriptors and consequent stage groupings in the forthcoming(seventh)edition of the TNM classification of malignant tumours[J]. J Thorac Oncol, 2007, 2(8):694-705.
  • 3Watanabe S, Oda M, Go T, et al. Should mediastinal nodal dissection be routinely unde-aken in patients with peripheral small-sized lung cancer? Retrospective analysis of 225 patients[J]. Eur J Cardiothorac Surg, 2001, 20(5): 1007-1011.
  • 4Noh J, Kim J, Ahn Y, et al. Effect of radiation therapy techniques on outcome in N3-positive IIIB non-small cell lung cancer treated with concurrent chemoradiotherapy [ J ]. Cancer Res Treat ,2015,2 (12) :2452-2455.
  • 5Schaake E, Rossi M, Buikhuisen W, et al. Differential motion be- tween mediastinal lymph nodes and primary tumor in radically ir- radiated lung cancer patients [ J ]. Int J Radiat Oncol Biol Phys 2014,90(4) :959-966.
  • 6Yoo I, Chung S, Park H, et al. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non- small cell lung cancer patients without LN metastasis [ J ]. Biomed Mater Eng,2014,24(6) :3091-3103.
  • 7Lee V, Chan W, Lee E, et al. Prognostic significance of standard- ized uptake value of lymph nodes on survival for stage III non- small cell lung cancer treated with definitive concurrent chemora- diotherapy[ J]. Am J Clin Oncal,2014,4(5 ) :42-47.
  • 8Feng W, Fu X, Cai X, et al. Patterns of local-regional failure in completely resected stage IIIA( N2 ) non-small cell lung cancer ca- ses:implications for postoperative radiation therapy clinical target volume design[ J]. Int J Radiat Oncol Biol Phys, 2014,88 (5) : 1100-1107.
  • 9Tanaka HI, Hayashi S, Hoshi H. Pretreatment maximum standard- ized uptake value on 18F-fluorodeoxyglucose positron emission tomography is a predictor of outcome for stage I non-small cell lung cancer after stereotactic body radiotherapy [ J ]. Asia Pac J Clin Oncol,2013,10(31 ) :543-549.
  • 10Griffioen G, Toguri D, Dahele M, et al. Radical treatment of syn- chronous oligometastatic non-small cell lung carcinoma ( NSCLC ) : patient outcomes and prognostic factors [ J ]. Lung Cancer,2013,82( 1 ) :95-102.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部